Edition:
United States

Profile: Piramal Enterprises Ltd (PIRA.NS)

PIRA.NS on National Stock Exchange of India

2,621.95INR
5:25am EST
Change (% chg)

Rs11.45 (+0.44%)
Prev Close
Rs2,610.50
Open
Rs2,613.00
Day's High
Rs2,649.00
Day's Low
Rs2,610.10
Volume
90,379
Avg. Vol
170,044
52-wk High
Rs3,088.95
52-wk Low
Rs1,430.05

Piramal Enterprises Limited (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries. The Company's pharmaceutical business consists of manufacturing and sale of own and traded bulk drugs and formulations. It operates through three segments: Healthcare, Financial Services and Information Management. Its Healthcare segment includes pharma solutions, critical care, consumer products and imaging. Its Financial Services segment includes wholesale lending, alternative asset management and investments in Shriram Group. Its Information Management segment is engaged in Decision Resources Group (DRG). DRG's product and services portfolio consists of data and analytics, research products and global consulting services. The Company offers its products under brands, including Saridon, Lacto Calamine, i-pill/i-know, Polycrol, Tetmosol, Untox, Stop AllerG and Throatsil.

Company Address

Piramal Enterprises Ltd

10th floor, Piramal Tower
Ganpatrao Kadam Marg
Lower Parel
MUMBAI     400013
P: +9122.30466666
F: +9122.24902363

Company Web Links